Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 41.78-15.6018.7817.2359.00

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 41.78 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202441.78
Mar2023-15.60
Mar202218.78
Mar202117.23
Mar202059.00

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2024 41.78
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23
-70.80
Mar2020 59 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses